Development and biological validation of an exosome-related gene signature for prognostic stratification in gastric cancer

Although genes associated with exosomes are implicated in the tumor microenvironment (TME), their clinical value for risk stratification in GC requires systemic evaluation. This study aims to construct an exosome-related gene signature-based prognostic model to predict prognosis and identify key oncogenic drivers in GC. We integrated bulk transcriptomics from The Cancer Genome Atlas (TCGA) database and the GSE84433 cohort with single-cell RNA sequencing (scRNA-seq) data to characterize the expression profiles of exosome-related genes. Unsupervised consensus clustering, sequential Cox regression and LASSO Cox regression were employed to construct a prognostic risk model. The associations between the risk signature, TME, and drug sensitivity were systematically analyzed. The functional roles of key candidate genes, DCBLD2 and GPC3, were validated in vitro via loss-of-function assays in GC cell lines. Based on the expression of exosome-related genes, we identified two distinct molecular subtypes with divergent prognoses and immune infiltration patterns. We subsequently constructed a robust six-gene prognostic signature (CRTAC1, DCBLD2, GRP, GPX3, GPC3, and TFF2). Patients in the high-risk group exhibited poorer survival, an immunosuppressive TME phenotype, and distinct drug sensitivities. Single-cell RNA sequencing analysis revealed preferential expression of DCBLD2 and GPC3 in fibroblast and epithelial populations, suggesting them as stromal-associated markers linked to malignant plasticity. In vitro validation confirmed that silencing DCBLD2 or GPC3 in AGS cells significantly suppressed cell proliferation, migration, and invasion by inducing apoptosis and G2/M cell cycle arrest. We developed a six-gene prognostic signature derived from exosome-related genes that effectively stratifies GC patients and reflects TME heterogeneity. Additionally, we experimentally validated DCBLD2 and GPC3 as critical oncogenic drivers, providing novel targets for further investigation in GC.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2026-11-21
DOI
https://doi.org/10.1186/s12876-026-05593-9
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and biological validation of an exosome-related gene signature for prognostic stratification in gastric cancer

Long-Kuan Yin, Qian Li, Jing Yang, Jun-Song Yang et al.
BMC Gastroenterology
Extracellular vesicles in disease
article

Development and biological validation of an exosome-related gene signature for prognostic stratification in gastric cancer

Long-Kuan Yin, Qian Li, Jing Yang, Jun-Song Yang, Jin Tang
article en

Abstract

Although genes associated with exosomes are implicated in the tumor microenvironment (TME), their clinical value for risk stratification in GC requires systemic evaluation. This study aims to construct an exosome-related gene signature-based prognostic model to predict prognosis and identify key oncogenic drivers in GC. We integrated bulk transcriptomics from The Cancer Genome Atlas (TCGA) database and the GSE84433 cohort with single-cell RNA sequencing (scRNA-seq) data to characterize the expression profiles of exosome-related genes. Unsupervised consensus clustering, sequential Cox regression and LASSO Cox regression were employed to construct a prognostic risk model. The associations between the risk signature, TME, and drug sensitivity were systematically analyzed. The functional roles of key candidate genes, DCBLD2 and GPC3, were validated in vitro via loss-of-function assays in GC cell lines. Based on the expression of exosome-related genes, we identified two distinct molecular subtypes with divergent prognoses and immune infiltration patterns. We subsequently constructed a robust six-gene prognostic signature (CRTAC1, DCBLD2, GRP, GPX3, GPC3, and TFF2). Patients in the high-risk group exhibited poorer survival, an immunosuppressive TME phenotype, and distinct drug sensitivities. Single-cell RNA sequencing analysis revealed preferential expression of DCBLD2 and GPC3 in fibroblast and epithelial populations, suggesting them as stromal-associated markers linked to malignant plasticity. In vitro validation confirmed that silencing DCBLD2 or GPC3 in AGS cells significantly suppressed cell proliferation, migration, and invasion by inducing apoptosis and G2/M cell cycle arrest. We developed a six-gene prognostic signature derived from exosome-related genes that effectively stratifies GC patients and reflects TME heterogeneity. Additionally, we experimentally validated DCBLD2 and GPC3 as critical oncogenic drivers, providing novel targets for further investigation in GC.

BMC Gastroenterology
Affiliated Hospital of North Sichuan Medical College (CN), Nanchong Central Hospital (CN)
Southwest Medical University
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon